Peritoneal pre-conditioning reduces macrophage marker expression in collagen-containing engineered vascular grafts
Source abstract
Abstract
Engineered vascular grafts have shown promise as arteriovenous shunts, but they have not yet progressed to clinical trials for coronary arteries <4 mm in diameter such as the coronary arteries. Control over initial biomaterial properties and remodeling are necessary to generate viable grafts. In this study, we blended collagen with a synthetic material, poly(ε-caprolactone), to modulate the post-grafting inflammatory response while avoiding aneurysmal-like dilation and failure that can occur with pure collagen grafts. We also used pre-implantation in an "in vivo bioreactor" to recruit autologous cells and improve patency after grafting. Electrospun conduits were pre-implanted within rat peritoneal cavities and then grafted autologously into abdominal aortae. Conduit collagen percentages and pre-implantation were tested for their impact on graft remodeling and patency. Burst pressures >2000 mmHg, reproducible expansion with systole/diastole, and maintenance of mechanical integrity were observed. More importantly, peritoneal pre-implantation reduced overall lipid oxidation, intimal layer thickness, and expression of an M1 macrophage marker. The condition with the most collagen, 25%, exhibited the lowest expression of macrophage markers but also resulted in a thicker intimal layer. Overall, the 10% collagen/PCL with peritoneal pre-implantation condition appeared to exhibit the best combination of responses, and may result in improved clinical graft viability. Statement of significance This manuscript describes a rodent study to systematically determine the benefits of both pre-implantation in the peritoneal cavity and specific ratios of collagen on engineered vascular graft viability. We show that pre-implantation had a significant benefit, including decreasing the expression of macrophage markers and reducing lipid oxidation after grafting. This study is the first time that the benefits of peritoneal pre-implantation have been compared to an "off the shelf," directly grafted control condition. We also demonstrated the importance of specific collagen ratio on the response after grafting. Overall, we feel that this article will be of interest to the field and it has the potential to address a significant clinical need: a graft for coronary arteries <4 mm in diameter.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Infectious Aortic and Vascular Conditions · Aortic aneurysm repair treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (65)
Show source-provided references
1. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature10.1016/j.ejvs.2003.12.027 ↗
2. Heart Association Statistics Committee and Stroke Statistics Subcommittee, Heart disease and stroke statistics–2012 update: a report from the American Heart Association
3. Tissue engineering of acellular vascular grafts capable of somatic growth in young lambs10.1038/ncomms12951 ↗
4. The tissue-engineered vascular graft-past, present, and future10.1089/ten.teb.2015.0100 ↗
5. In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model10.1089/ten.tea.2009.0427 ↗
6. Compositions including synthetic and natural blends for integration and structural integrity: engineered for different vascular graft applications10.1002/adhm.201700001 ↗
7. Substrate rigidity and force define form through tyrosine phosphatase and kinase pathways10.1016/j.tcb.2006.02.005 ↗
8. Immune response to biologic scaffold materials10.1016/j.smim.2007.11.003 ↗
9. Monocyte chemotactic activity in human abdominal aortic aneurysms: role of elastin degradation peptides and the 67-kD cell surface elastin receptor10.1067/mva.2002.120382 ↗
10. Effects of polyglycolic acid on porcine smooth muscle cell growth and differentiation10.1002/jbm.a.10599 ↗
11. Arterial regeneration over absorbable prostheses10.1067/mva.2003.88 ↗
12. Vascular tissue engineering10.1146/annurev.bioeng.3.1.225 ↗
13. Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine10.1016/j.biomaterials.2012.02.034 ↗
14. Multilayer composite scaffolds with mechanical properties similar to small intestinal submucosa10.1002/jbm.a.31903 ↗
15. Natural and synthetic biodegradable polymers: different scaffolds for cell expansion and tissue formation10.5301/ijao.5000307 ↗
16. Stem cell differentiation on electrospun nanofibrous substrates for vascular tissue engineering10.1016/j.msec.2013.07.021 ↗
17. The effect of biomaterials used for tissue regeneration purposes on polarization of macrophages10.1089/biores.2015.0041 ↗
18. Biomaterial based modulation of macrophage polarization: a review and suggested design principles10.1016/j.mattod.2015.01.019 ↗
19. Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype10.1152/japplphysiol.01114.2004 ↗
20. Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering10.1089/ten.teb.2009.0630 ↗
21. Type I collagen promotes modulation of cultured rabbit arterial smooth muscle cells from a contractile to a synthetic phenotype10.1006/excr.1993.1016 ↗
22. In vitro and in vivo analysis of co-electrospun scaffolds made of medical grade poly(ε-caprolactone) and porcine collagen10.1163/156856208784089580 ↗
23. Collagen incorporation within electrospun conduits reduces lipid oxidation and impacts conduit mechanics10.1088/1748-6041/11/2/025019 ↗
24. Dog peritoneal and pleural cavities as bioreactors to grow autologous vascular grafts10.1016/j.jvs.2003.03.003 ↗
25. In vitro study of endothelial cells lining vascular grafts grown within the recipient’s peritoneal cavity10.1089/ten.tea.2007.0219 ↗
26. Gene expression profile of the fibrotic response in the peritoneal cavity10.1016/j.diff.2010.03.001 ↗
27. Bioengineered vascular graft grown in the mouse peritoneal cavity10.1016/j.jvs.2010.05.015 ↗
28. Composition of intraperitoneally implanted electrospun conduits modulates cellular elastic matrix generation10.1016/j.actbio.2013.08.042 ↗
29. Role of reactive oxygen species in inhibition of endothelial cell migration by oxidized low-density lipoprotein10.1016/j.jvs.2004.09.020 ↗
30. Aligned electrospun scaffolds and elastogenic factors for vascular cell-mediated elastic matrix assembly10.1002/term.470 ↗
31. Fabrication of burst pressure competent vascular grafts via electrospinning: effects of microstructure10.1002/jbm.a.31926 ↗
32. Biodegradation of bicomponent PCL/gelatin and PCL/collagen nanofibers electrospun from alternative solvent system10.1016/j.polymdegradstab.2016.05.022 ↗
33. Determination of layer-specific mechanical properties of human coronary arteries with nonatherosclerotic intimal thickening and related constitutive modeling10.1152/ajpheart.00934.2004 ↗
34. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis10.1194/jlr.M007096 ↗
35. Effect of fiber diameter and alignment of electrospun polyurethane meshes on mesenchymal progenitor cells10.1089/ten.tea.2008.0295 ↗
36. A kinetic-based sigmoidal model for the polymerase chain reaction and its application to high-capacity absolute quantitative real-time PCR10.1186/1472-6750-8-47 ↗
37. Host response to xenograft ECM implantation is not different between the shoulder and body wall sites in the rat model10.1002/jor.22149 ↗
38. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling10.1073/pnas.0911465107 ↗
39. Effect of fiber diameter and orientation on fibroblast morphology and proliferation on electrospun poly(D, L-lactic-co-glycolic acid) meshes10.1016/j.biomaterials.2006.07.005 ↗
40. Characterization of a PLLA-collagen I blend nanofiber scaffold with respect to growth and osteogenic differentiation of human mesenchymal stem cells10.1100/tsw.2009.13 ↗
41. Electrospun poly (epsilon-caprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: characterization of scaffolds and measurement of cellular infiltration10.1021/bm060680j ↗
42. Influence of the fiber diameter and surface roughness of electrospun vascular grafts on blood activation10.1016/j.actbio.2012.07.032 ↗
43. Haemopoietic origin of myofibroblasts formed in the peritoneal cavity in response to a foreign body10.1159/000025752 ↗
44. Antithrombogenic Modification of Small-Diameter Microfibrous Vascular Grafts10.1161/ATVBAHA.110.208348 ↗
45. Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoartery10.1038/nm.2821 ↗
46. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives10.1152/physrev.00047.2009 ↗
47. Experimental noninferiority trial of synthetic small-caliber biodegradable versus stable vascular grafts10.1016/j.jtcvs.2012.09.054 ↗
48. Computational predictions of the tensile properties of electrospun fibre meshes: effect of fibre diameter and fibre orientation10.1016/j.jmbbm.2008.01.003 ↗
49. Spatial and temporal changes in compliance following implantation of bioresorbable vascular grafts10.1002/jbm.820261105 ↗
50. In vivo performance of a phospholipid-coated bioerodable elastomeric graft for small-diameter vascular applications10.1002/jbm.a.32997 ↗
51. Macrophage phenotype as a determinant of biologic scaffold remodeling10.1089/ten.tea.2007.0264 ↗
52. Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin10.1083/jcb.147.3.619 ↗
53. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules10.1016/S0002-9440(10)65020-1 ↗
54. Expanded applications, shifting paradigms and an improved understanding of host-biomaterial interactions10.1016/j.actbio.2012.10.025 ↗
55. Halofuginone, a specific collagen type I inhibitor, reduces anastomotic intimal hyperplasia10.1001/archsurg.1995.01430030027004 ↗
56. Reactive Oxygen Species and Cell Signaling10.1164/rccm.2206007 ↗
57. Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease10.1016/j.freeradbiomed.2006.09.001 ↗
58. Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation10.1007/BF00229586 ↗
59. Differential PDGF secretion by graft and aortic SMC in response to oxidized LDL10.1152/ajpheart.00060.2002 ↗
60. Deconstructing the tissue engineered vascular graft: evaluating scaffold pre-wetting, conditioned media incubation, and determining the optimal mononuclear cell source
61. Tissue engineering and regenerative strategies to replicate biocomplexity of vascular elastic matrix assembly10.1089/ten.teb.2011.0521 ↗
62. Spatiotemporal mapping of matrix remodelling and evidence of in situ elastogenesis in experimental abdominal aortic aneurysms10.1002/term.1905 ↗
63. Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: preliminary studies10.1067/mva.2003.63 ↗
64. Von Willebrand factor inhibits mature smooth muscle gene expression through impairment of Notch signaling10.1371/journal.pone.0075808 ↗
65. von Willebrand factor: two sides of a coin10.1111/j.1538-7836.2005.01369.x ↗